PDB Short entry for 4AXA HEADER TRANSFERASE/TRANSFERASE INHIBITOR 12-JUN-12 4AXA TITLE STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1S)-2-AMINO-1-( TITLE 2 4-CHLOROPHENYL)-1-(4-(1H-PYRAZOL-4-YL)PHENYL)ETHAN-1-OL COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 10 CHAIN: I; COMPND 11 FRAGMENT: RESIDUES 6-25; COMPND 12 SYNONYM: PKI-ALPHA, CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 13 MUSCLE/BRAIN ISOFORM SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606 KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.G.DAVIES,T.A.YAP,M.I.WALTON,K.M.GRIMSHAW,R.H.TEPOELE,P.D.EVE, AUTHOR 2 M.R.VALENTI,A.K.DEHAVENBRANDON,V.MARTINS,A.ZETTERLUND,S.P.HEATON, AUTHOR 3 K.HEINZMANN,P.S.JONES,R.E.FELTELL,M.REULE,S.J.WOODHEAD,J.F.LYONS, AUTHOR 4 F.I.RAYNAUD,S.A.ECCLES,P.WORKMAN,N.T.THOMPSON,M.D.GARRETT REVDAT 2 06-FEB-13 4AXA 1 HETATM REVDAT 1 25-JUL-12 4AXA 0 JRNL AUTH T.A.YAP,M.I.WALTON,K.M.GRIMSHAW,R.H.TE POELE,P.D.EVE, JRNL AUTH 2 M.R.VALENTI,A.K.DE HAVEN BRANDON,V.MARTINS,A.ZETTERLUND, JRNL AUTH 3 S.P.HEATON,K.HEINZMANN,P.S.JONES,R.E.FELTELL,M.REULE, JRNL AUTH 4 S.J.WOODHEAD,T.G.DAVIES,J.F.LYONS,F.I.RAYNAUD,S.A.ECCLES, JRNL AUTH 5 P.WORKMAN,N.T.THOMPSON,M.D.GARRETT JRNL TITL AT13148 IS A NOVEL, ORAL MULTI-AGC KINASE INHIBITOR WITH JRNL TITL 2 POTENT PHARMACODYNAMIC AND ANTITUMOR ACTIVITY. JRNL REF CLIN.CANCER RES. V. 18 3912 2012 JRNL REFN ISSN 1078-0432 JRNL PMID 22781553 JRNL DOI 10.1158/1078-0432.CCR-11-3313 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0025 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 95.39 REMARK 3 NUMBER OF REFLECTIONS : 31829 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.21628 REMARK 3 R VALUE (WORKING SET) : 0.21406 REMARK 3 FREE R VALUE : 0.25584 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 1720 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.900 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.949 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1860 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 77.76 REMARK 3 BIN R VALUE (WORKING SET) : 0.353 REMARK 3 BIN FREE R VALUE SET COUNT : 115 REMARK 3 BIN FREE R VALUE : 0.361 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2949 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 328 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.917 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.75 REMARK 3 B22 (A**2) : 0.31 REMARK 3 B33 (A**2) : -1.06 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.177 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.162 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.120 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.686 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3049 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2905 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4116 ; 1.351 ; 1.949 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6679 ; 0.753 ; 2.994 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 357 ; 5.645 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 152 ;36.158 ;23.750 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 547 ;14.009 ;15.082 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;17.587 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 427 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3407 ; 0.000 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 747 ; 0.000 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 15 A 125 REMARK 3 ORIGIN FOR THE GROUP (A): 4.4344 13.6716 -6.3728 REMARK 3 T TENSOR REMARK 3 T11: 0.0103 T22: 0.0905 REMARK 3 T33: 0.1125 T12: 0.0196 REMARK 3 T13: -0.0231 T23: 0.0090 REMARK 3 L TENSOR REMARK 3 L11: 0.9877 L22: 1.8915 REMARK 3 L33: 2.8026 L12: -0.1878 REMARK 3 L13: -0.5973 L23: 0.0854 REMARK 3 S TENSOR REMARK 3 S11: -0.0156 S12: -0.0205 S13: 0.0759 REMARK 3 S21: -0.0769 S22: 0.0236 S23: 0.2664 REMARK 3 S31: -0.0869 S32: -0.3288 S33: -0.0080 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : I 5 I 24 REMARK 3 RESIDUE RANGE : A 126 A 350 REMARK 3 ORIGIN FOR THE GROUP (A): 12.0171 -3.4780 -0.3704 REMARK 3 T TENSOR REMARK 3 T11: 0.0508 T22: 0.0388 REMARK 3 T33: 0.0397 T12: -0.0246 REMARK 3 T13: 0.0164 T23: -0.0089 REMARK 3 L TENSOR REMARK 3 L11: 1.1012 L22: 1.5942 REMARK 3 L33: 2.8208 L12: -0.2458 REMARK 3 L13: 0.3229 L23: -0.7847 REMARK 3 S TENSOR REMARK 3 S11: -0.0071 S12: -0.0250 S13: -0.0456 REMARK 3 S21: -0.0716 S22: -0.0155 S23: 0.0284 REMARK 3 S31: 0.3249 S32: -0.0980 S33: 0.0226 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 4AXA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JUN-12. REMARK 100 THE PDBE ID CODE IS EBI-52861. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35112 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.90 REMARK 200 RESOLUTION RANGE LOW (A) : 54.60 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NONE REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 2.3 REMARK 200 R MERGE (I) : 0.05 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.80 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.34 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.45700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.09200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.33200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.09200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.45700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.33200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 LYS A 8 REMARK 465 GLY A 9 REMARK 465 SER A 10 REMARK 465 GLU A 11 REMARK 465 GLN A 12 REMARK 465 GLU A 13 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2031 O HOH A 2043 1.96 REMARK 500 O HOH A 2090 O HOH A 2094 2.01 REMARK 500 O HOH A 2093 O HOH A 2210 1.93 REMARK 500 O HOH A 2098 O HOH A 2183 2.01 REMARK 500 O HOH A 2099 O HOH A 2210 2.03 REMARK 500 O HOH A 2120 O HOH A 2239 2.03 REMARK 500 O HOH A 2285 O HOH A 2288 1.84 REMARK 500 O HOH I 2034 O HOH I 2035 1.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RKD A1351 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CMK RELATED DB: PDB REMARK 900 RELATED ID: 1JLU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP- REMARK 900 DEPENDENT PROTEIN KINASE COMPLEXED WITH A REMARK 900 PHOSPHORYLATEDSUBSTRATE PEPTIDE AND DETERGENT REMARK 900 RELATED ID: 1KMU RELATED DB: PDB REMARK 900 MODEL STRUCTURE OF THE CATALYTIC SUBUNIT-REGULATORY REMARK 900 SUBUNITDIMERIC COMPLEX OF THE CAMP-DEPENDENT PROTEIN REMARK 900 KINASE REMARK 900 RELATED ID: 1KMW RELATED DB: PDB REMARK 900 MODEL STRUCTURE OF THE CATALYTIC SUBUNIT-REGULATORY REMARK 900 SUBUNITDIMERIC COMPLEX OF THE C-AMP-DEPENDENT PROTEIN REMARK 900 KINASE REMARK 900 RELATED ID: 1Q24 RELATED DB: PDB REMARK 900 PKA DOUBLE MUTANT MODEL OF PKB IN COMPLEX WITH MGATP REMARK 900 RELATED ID: 1Q61 RELATED DB: PDB REMARK 900 PKA TRIPLE MUTANT MODEL OF PKB REMARK 900 RELATED ID: 1Q62 RELATED DB: PDB REMARK 900 PKA DOUBLE MUTANT MODEL OF PKB REMARK 900 RELATED ID: 1Q8T RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE( REMARK 900 PKA) IN COMPLEX WITH RHO-KINASE INHIBITOR Y-27632 REMARK 900 RELATED ID: 1Q8U RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE REMARK 900 INCOMPLEX WITH RHO-KINASE INHIBITOR H-1152P REMARK 900 RELATED ID: 1Q8W RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE REMARK 900 INCOMPLEX WITH RHO-KINASE INHIBITOR FASUDIL (HA-1077) REMARK 900 RELATED ID: 1SMH RELATED DB: PDB REMARK 900 PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED REMARK 900 N-TERMINAL HELIX REMARK 900 RELATED ID: 1STC RELATED DB: PDB REMARK 900 CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT REMARK 900 INCOMPLEX WITH STAUROSPORINE REMARK 900 RELATED ID: 1SVE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX REMARK 900 WITHAZEPANE DERIVATIVE 1 REMARK 900 RELATED ID: 1SVG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX REMARK 900 WITHAZEPANE DERIVATIVE 4 REMARK 900 RELATED ID: 1SVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX REMARK 900 WITHAZEPANE DERIVATIVE 8 REMARK 900 RELATED ID: 1SZM RELATED DB: PDB REMARK 900 DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO REMARK 900 PROTEINKINASE A (PKA) REMARK 900 RELATED ID: 1VEB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX REMARK 900 WITHAZEPANE DERIVATIVE 5 REMARK 900 RELATED ID: 1XH4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE REMARK 900 INHIBITORSIN COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE REMARK 900 INHIBITORSIN COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE REMARK 900 INHIBITORSIN COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE REMARK 900 INHIBITORSIN COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE REMARK 900 INHIBITORSIN COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE REMARK 900 INHIBITORSIN COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XHA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE REMARK 900 INHIBITORSIN COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1YDR RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA- REMARK 900 CATALYTICSUBUNIT IN COMPLEX WITH H7 PROTEIN KINASE REMARK 900 INHIBITOR1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE REMARK 900 RELATED ID: 1YDS RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA- REMARK 900 CATALYTICSUBUNIT IN COMPLEX WITH H8 PROTEIN KINASE REMARK 900 INHIBITOR[N-(2-METHYLAMINO)ETHYL]-5- REMARK 900 ISOQUINOLINESULFONAMIDE REMARK 900 RELATED ID: 1YDT RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA- REMARK 900 CATALYTICSUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE REMARK 900 INHIBITORN-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE REMARK 900 RELATED ID: 2C1A RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED REMARK 900 WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4- REMARK 900 CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE REMARK 900 RELATED ID: 2C1B RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED REMARK 900 WITH (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2- REMARK 900 YLMETHANESULFONYL)ISOQUINOLINE REMARK 900 RELATED ID: 2F7E RELATED DB: PDB REMARK 900 PKA COMPLEXED WITH (S)-2-(1H-INDOL-3-YL)-1-(5- REMARK 900 ISOQUINOLIN-6-YL-PYRIDIN-3-YLOXYMETHYL-ETYLAMINE REMARK 900 RELATED ID: 2GFC RELATED DB: PDB REMARK 900 CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT REMARK 900 WITHPKI-5-24 REMARK 900 RELATED ID: 2GNF RELATED DB: PDB REMARK 900 PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE REMARK 900 WITH Y-27632 REMARK 900 RELATED ID: 2GNG RELATED DB: PDB REMARK 900 PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE REMARK 900 RELATED ID: 2GNH RELATED DB: PDB REMARK 900 PKA FIVE FOLD MUTANT MODEL OF RHO-KINASE WITH H1152P REMARK 900 RELATED ID: 2GNI RELATED DB: PDB REMARK 900 PKA FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH REMARK 900 INHIBITORFASUDIL (HA1077) REMARK 900 RELATED ID: 2GNJ RELATED DB: PDB REMARK 900 PKA THREE FOLD MUTANT MODEL OF RHO-KINASE WITH Y- REMARK 900 27632 REMARK 900 RELATED ID: 2GNL RELATED DB: PDB REMARK 900 PKA THREEFOLD MUTANT MODEL OF RHO-KINASE WITH REMARK 900 INHIBITOR H-1152P REMARK 900 RELATED ID: 2JDS RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED REMARK 900 WITH A-443654 REMARK 900 RELATED ID: 2JDT RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE REMARK 900 -5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO) REMARK 900 ETHYL)AMIDE REMARK 900 RELATED ID: 2JDV RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654 REMARK 900 RELATED ID: 2UVX RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7- REMARK 900 AZAINDOLE REMARK 900 RELATED ID: 2UVY RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4 REMARK 900 -(9H-PURIN-6-YL)-BENZYL)-AMINE REMARK 900 RELATED ID: 2UVZ RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL- REMARK 900 C-(4-(9H-PURIN-6-YL)-PHENYL)-METHYLAMINE REMARK 900 RELATED ID: 2UW0 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 6-(4-(4 REMARK 900 -(4-CHLORO-PHENYL)-PIPERIDIN-4-YL)-PHENYL)-9H-PURINE REMARK 900 RELATED ID: 2UW3 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL- REMARK 900 4-PHENYL-1H-PYRAZOLE REMARK 900 RELATED ID: 2UW4 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5 REMARK 900 -METHYL-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE REMARK 900 RELATED ID: 2UW5 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (R)-2-(4 REMARK 900 -CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)- REMARK 900 ETHYLAMINE REMARK 900 RELATED ID: 2UW6 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (S)-2-(4 REMARK 900 -CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)- REMARK 900 ETHYLAMINE REMARK 900 RELATED ID: 2UW7 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4- REMARK 900 CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)- REMARK 900 PIPERIDINE REMARK 900 RELATED ID: 2UW8 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4- REMARK 900 CHLORO-PHENYL)-2-PHENYL-ETHYLAMINE REMARK 900 RELATED ID: 2UZT RELATED DB: PDB REMARK 900 PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE INHIBITORS REMARK 900 RELATED ID: 2UZU RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2UZV RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2UZW RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2VNW RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H- REMARK 900 PURIN-6-YL)PIPERIDIN-4-YL)METHANAMINE REMARK 900 RELATED ID: 2VNY RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H- REMARK 900 PURIN-6-YL)PIPERIDIN-4-YL)AMINE REMARK 900 RELATED ID: 2VO0 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4 REMARK 900 -CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL) REMARK 900 PIPERIDIN-4-YL)METHYLAMINE REMARK 900 RELATED ID: 2VO3 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4 REMARK 900 -CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL) REMARK 900 PIPERIDIN-4-YL)METHYLAMINE REMARK 900 RELATED ID: 2VO6 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4- REMARK 900 CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL) REMARK 900 PIPERIDIN-4-YLAMINE REMARK 900 RELATED ID: 2VO7 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1 REMARK 900 -(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4- REMARK 900 YLAMINE REMARK 999 REMARK 999 SEQUENCE REMARK 999 4 RESIDUES OF THE WILD-TYPE PKA SEQUENCE HAVE BEEN MUTATED REMARK 999 TO THE CORRESPONDING RESIDUES IN PKB DBREF 4AXA A 0 350 UNP P00517 KAPCA_BOVIN 1 351 DBREF 4AXA I 5 24 UNP P61925 IPKA_HUMAN 6 25 SEQADV 4AXA THR A 104 UNP P00517 VAL 105 ENGINEERED MUTATION SEQADV 4AXA ALA A 123 UNP P00517 VAL 124 ENGINEERED MUTATION SEQADV 4AXA MET A 173 UNP P00517 LEU 174 ENGINEERED MUTATION SEQADV 4AXA LYS A 181 UNP P00517 GLN 182 ENGINEERED MUTATION SEQRES 1 A 351 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN SEQRES 2 A 351 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 A 351 PHE LEU LYS LYS TRP GLU ASN PRO ALA GLN ASN THR ALA SEQRES 4 A 351 HIS LEU ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR SEQRES 5 A 351 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS MET GLU SEQRES 6 A 351 THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 A 351 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 A 351 GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 A 351 THR LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 A 351 TYR MET VAL MET GLU TYR ALA PRO GLY GLY GLU MET PHE SEQRES 11 A 351 SER HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS SEQRES 12 A 351 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 A 351 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 A 351 PRO GLU ASN LEU MET ILE ASP GLN GLN GLY TYR ILE LYS SEQRES 15 A 351 VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 A 351 THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO SEQRES 17 A 351 GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP SEQRES 18 A 351 TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA SEQRES 19 A 351 GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE SEQRES 20 A 351 TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER SEQRES 21 A 351 HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU SEQRES 22 A 351 LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS SEQRES 23 A 351 ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA SEQRES 24 A 351 THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU SEQRES 25 A 351 ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SEQRES 26 A 351 SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEQRES 27 A 351 SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP MODRES 4AXA TPO A 197 THR PHOSPHOTHREONINE MODRES 4AXA SEP A 338 SER PHOSPHOSERINE HET TPO A 197 11 HET SEP A 338 10 HET RKD A1351 39 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM RKD (2S)-2-(4-CHLOROPHENYL)-2-HYDROXY-2-[4-(1H- HETNAM 2 RKD PYRAZOL-4-YL)PHENYL]ETHANAMINIUM HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 3 TPO C4 H10 N O6 P FORMUL 4 SEP C3 H8 N O6 P FORMUL 5 RKD C17 H17 CL N3 O 1+ FORMUL 6 HOH *328(H2 O) HELIX 1 1 SER A 14 ASN A 32 1 19 HELIX 2 2 HIS A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLN A 84 GLN A 96 1 13 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 SER A 139 LEU A 160 1 22 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 THR A 201 LEU A 205 5 5 HELIX 9 9 ALA A 206 LEU A 211 1 6 HELIX 10 10 LYS A 217 GLY A 234 1 18 HELIX 11 11 GLN A 242 GLY A 253 1 12 HELIX 12 12 SER A 262 LEU A 273 1 12 HELIX 13 13 VAL A 288 ASN A 293 1 6 HELIX 14 14 HIS A 294 ALA A 298 5 5 HELIX 15 15 ASP A 301 GLN A 307 1 7 HELIX 16 16 THR I 5 SER I 13 1 9 SHEET 1 AA 5 PHE A 43 THR A 51 0 SHEET 2 AA 5 GLY A 55 HIS A 62 -1 O VAL A 57 N LEU A 49 SHEET 3 AA 5 HIS A 68 ASP A 75 -1 O TYR A 69 N VAL A 60 SHEET 4 AA 5 ASN A 115 GLU A 121 -1 O LEU A 116 N LEU A 74 SHEET 5 AA 5 LEU A 106 LYS A 111 -1 N GLU A 107 O VAL A 119 SHEET 1 AB 2 LEU A 162 ILE A 163 0 SHEET 2 AB 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AC 2 LEU A 172 ILE A 174 0 SHEET 2 AC 2 ILE A 180 VAL A 182 -1 O LYS A 181 N MET A 173 LINK N TPO A 197 C TRP A 196 1555 1555 1.32 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.34 LINK N SEP A 338 C VAL A 337 1555 1555 1.33 SITE 1 AC1 17 GLY A 50 THR A 51 GLY A 52 GLY A 55 SITE 2 AC1 17 VAL A 57 ALA A 70 GLU A 121 TYR A 122 SITE 3 AC1 17 ALA A 123 GLU A 127 GLU A 170 ASN A 171 SITE 4 AC1 17 MET A 173 THR A 183 ASP A 184 HOH A2139 SITE 5 AC1 17 HOH A2178 CRYST1 72.914 74.664 80.184 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013715 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013393 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012471 0.00000